A carregar...
Selecting an Optimal Antiplatelet Agent for Secondary Stroke Prevention
Four seminal randomized controlled trials (RCTs) have investigated aspirin, aspirin plus extended-release dipyridamole, and clopidogrel for the prevention of recurrent vascular events. Despite studying over 32,000 patients with stroke in these trials, the decision on which antiplatelet agent to sele...
Na minha lista:
| Publicado no: | Neurol Clin Pract |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8032446/ https://ncbi.nlm.nih.gov/pubmed/33842080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000842 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|